Aurobindo Pharma has incorporated a Wholly Owned Subsidiary (WoS) in the name of ‘Auro Trading’ on November 22, 2023. Auro Trading is incorporated for carrying on trading in generic formulations business.
Aurobindo Pharma is engaged in manufacturing pharmaceutical products. It offers active pharmaceutical ingredients, intermediates and generic formulations like astemizole, domeperidone and omeprazole; anti-infective, oral and sterile antibiotics, pain management and osteoporosis segments.